Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.
about
Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Outcomes in Patients With Meta ...... the RECORD-1 and REACT Trials.
@en
Outcomes in Patients With Meta ...... the RECORD-1 and REACT Trials.
@nl
type
label
Outcomes in Patients With Meta ...... the RECORD-1 and REACT Trials.
@en
Outcomes in Patients With Meta ...... the RECORD-1 and REACT Trials.
@nl
prefLabel
Outcomes in Patients With Meta ...... the RECORD-1 and REACT Trials.
@en
Outcomes in Patients With Meta ...... the RECORD-1 and REACT Trials.
@nl
P2093
P2860
P1476
Outcomes in Patients With Meta ...... the RECORD-1 and REACT Trials.
@en
P2093
Camillo Porta
Chinjune Lin
Istvan Bodrogi
Jean-Pascal Machiels
John A Thompson
Maurizio Voi
Mert Basaran
Petri Bono
Robert A Figlin
Robert J Motzer
P2860
P304
P356
10.1016/J.CLGC.2016.04.011
P407
P577
2016-04-27T00:00:00Z